Nefazodone in post-traumatic stress disorder: Results from six open-label trials

International Clinical Psychopharmacology

Volumn 14, Issue 2, 1999, Pages 61-68

  Hidalgo, R ^a   Hertzberg, M A ^a,b   Mellman, T ^g   Petty, F ^g   Tucker, P ^c   Weisler, R ^a,d   Zisook, S ^e   Chen, S ^f   Churchill, E ^a   Davidson, J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d Private Practice   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f BRISTOL MYERS SQUIBB   (United States)

^g Duke University Medical Center ^*

Author keywords

Nefazodone; Post traumatic stress disorder; Predictor; Response

Indexed keywords

ANTIDEPRESSANT AGENT; NEFAZODONE;

ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; META ANALYSIS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SOLDIER;

EID: 0033034391     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199903000-00001     Document Type: Article

References (35)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
2. Armitage R, Yonkers K, Cole D, Rush J (1997) A multi-center, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol 17:161-168.
3. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Klauminzer G, Charney D, Keane TM (1990) A clinician rating scale for assessing current an lifetime PTSD: the CAPS-1. Behav Ther 13:187-188.
4. Breslau N, Kesler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P (1998) Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 55(7):626-632.
5. Caplik J, Talukder E, Roberts D, Keusler T, Schwiderski UE (1994) Nefazodone and body weight change: a comparison of nefazodone and imipramine in placebo-controlled trials of treatment for major depression. Neuropsychopharmacology 10 (Suppl. 3):220S.
6. Cohn CK, Robinson DS, Douglas LR, Schwiderski UE, O'Brien K, Ieni JR (1996) Responders to antidepressant drug treatment: a study comparing nefazodone, imipramime, and placebo in-patients with major depression. J Clin Psychiatry 57 (Suppl. 2):15-18.
7. Davidson JRT, Hughes D, Blazer DG (1991) Posttraumatic stress disorder in the community: an epidemiological study. Psychol Med 21:713-721.
8. Davidson JRT (1997) Biological therapies for post-traumatic stress disorder: an overview. J Clin Psychiatry 58 (Suppl. 9):29-32.
9. Davidson JRT, Malik MA, Travers J (1997) SIP: the structure interview for PTSD. Psychometric validation for DSM-IV criteria. Depression Anxiety 5:127-129.
10. Davidson JRT, Weisler, Malik MA, Connor KM (1998) Treatment of post-traumatic stress disorder with nefazodone. Int Clin Psychopharmacology 13:111-113.
11. Davis R, Whittington R, Bryson HM (1997) Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Drugs 54:608-636.
12. Davis LL, Nugent A, Clark M, Murray J, Kramer G, Petty F (1998) Nefazodone Treatment for Chronic Post-traumatic Stress Disorder: An Open Trial. Boca Raton, FL: New Clinical Drug Evaluation Unit Program.
13. Davis R, Whittington R, Bryson HM (1997) Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Drugs 54:608-636.
14. Fawcett J, Marcus R, Anton S, O'Brien K, Schwiderski U (1995) Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatry 56 (Suppl. 6):37-42.
15. Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA (1998) A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression. J Clin Psychiatry 59:246-253.
16. Foa EB, Riggs DS, Dancu CV, Rothbaum BO (1993) Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Traumatic Stress 5:459-472.
17. Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, et al. (1994) A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatry 55:234-241.
18. Gillin JC, Rapaport M, Erman M, Winokur A, Albala B (1997) A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8 week clinical trial. J Clin Psychiatry 58:185-192.
19. Hertzberg MA, Feldman ME, Beckhan JC, Davidson JRT (1996) Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 16:294-298.
20. Hertzberg MA, Feldman ME, Beckman JC, Moore SM, Davidson JRT (1998) Open trial of nefazodone for combat-related post-traumatic disorder. J Clin Psychiatry 59:460-464.
21. Katz L, Fleisher W, Kjernisted K, Milanese P (1996) A review of the Psychobiology and pharmacotherapy of post-traumatic stress disorder. Can J Psychiatry 41:233-238.
22. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52:1048-1060.
23. Marshall D, Davidson JRT, Yehuda R (1998) Pharmacotherapy in the treatment of post-traumatic stress disorder and other trauma-related syndromes; psychological trauma. In: Review of Psychiatry (R Yehuda, ed.), Washington, DC: American Psychiatric Press. pp. 133-177.
24. Mellman TA, Kullick-Bell R, Ashlock LE, Nolan B (1995) Sleep events in combat-related post-traumatic stress disorder. Am J Psychiatry 152:110-115.
25. Mellman TA, David D, Barza L (1997) Pilot study of nefazodone for chronic PTSD and related sleep disturbance. Paper presented at the Annual Meeting of the American Psychiatric Association, San Diego, CA.
26. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzwngeza S, de Montigny C, Blier P, Diksic M (1997) Differences between males and females in rates of serolonin synthesis in human brain. Proc Natl Acad Sci USA 94:5308-5313.
27. Rascati K (1995) Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. Clin Therap 17:786-790.
28. Robinson D, Roberts DL, Smith JM, Stringfellow JC, Kaplita SB, Seminara JA et al. (1996) The safety profile of nefazodone. J Clin Psychiatry 57 (Suppl. 2):31-38.
29. Rush JA, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, et al. (1998) Comparative effects of nefazodone and fluoxetine on sleep in outpatients wild major depressive disorder. Biol Psychiatry 44:3-14.
30. Shalev AJ, Bonne O, Spencer E (1996) Treatment of post-traumatic stress disorder: a review. Psychosomat Med 58:165-182.
31. Solomon S, Davidson JRT (1997) Trauma: prevalence, impairment, service use, and cost. J Clin Psychiatry 58 (Suppl 9):2-11.
32. Sussman N, Ginsberg D (1998) Rethinking side effects of the selective reuptake inhibitors: sexual dysfunction and weight gain. Psychiatr Ann 28:89-97.
33. Tucker PM, Smith MS, Jones D, Carson M, Bhupalhiraju R (1998) Nefazodone in PTSD: Effects on Symptoms and Physiological Reactivity. Boca Raton, FL: New Clinical Drug Evaluation Unit Program.
34. Zajecka J (1996) The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice an psychiatric outpatient settings. J Clin Psychiatry 57 (Suppl. 2):10-14.
35. Zisook, S, Chentsova-Dutton Y, Ellenor G, Kodsy A, Smith-Vaniz A, Kline NA. (1998) Nefazodone in patients with treatment-refractory PTSD. Presented at the Annual Meeting of the American Psychiatric Association, Toronto, Ontario, Canada.